A groundbreaking study has unveiled a critical issue of therapeutic inertia in treating women with medlinkmultiple sclerosis/medlink (MS),...
Vous n'êtes pas connecté
WEDNESDAY, Sept. 18, 2024 -- Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure paramagnetic rim lesions...
A groundbreaking study has unveiled a critical issue of therapeutic inertia in treating women with medlinkmultiple sclerosis/medlink (MS),...
TUESDAY, Sept. 17, 2024 -- Brain training aimed at improving memory can ward off symptoms of Alzheimer’s disease for years, a new study...
A new study reveals how gender disparities cause therapeutic inertia in MS treatment for women, highlighting delays and reduced use of crucial...
Quantum BioPharma (CSE:QNTM) will conduct a study observing disease progression in patients with primary progressive multiple sclerosis.
TUESDAY, Sept. 10, 2024 -- A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame...
Sulthiame may help prevent patients’ breathing from temporarily stopping, international research suggests
New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...
Cognitive decline and dementia can be caused by illnesses like Alzheimer’s disease and conditions like high blood pressure, which damage blood...